Details for New Drug Application (NDA): 013615
✉ Email this page to a colleague
NDA 013615 describes QUIDE, which is a drug marketed by Dow Pharm and is included in one NDA. Additional details are available on the QUIDE profile page.
The generic ingredient in QUIDE is piperacetazine. There is one drug master file entry for this compound. Additional details are available on the piperacetazine profile page.
The generic ingredient in QUIDE is piperacetazine. There is one drug master file entry for this compound. Additional details are available on the piperacetazine profile page.
Summary for 013615
| Tradename: | QUIDE |
| Applicant: | Dow Pharm |
| Ingredient: | piperacetazine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
